Cannabidiol (CBD) has been getting intense interest by science for its potential use in treating a wide range of medical conditions. In 2015 the National Institute on Drug Abuse (NIDA) made a statement that “pre-clinical research (including both cell culture and animal models) has shown CBD to have a range of effects that may be therapeutically useful,” and research seeks to expand upon how exactly cannabidiol can benefit patients.

NIDA also stated that “several pre-clinical reports showing anti-tumor effects of CBD…have found reduced [cancer] cell viability, increased cancer cell death, decreased tumor growth, and inhibition of metastasis.” The National Cancer Institute (NCI) also has reported that cannabidiol and other cannabinoids can provide a “protective effect against the development of certain types of tumors.”

Furthermore the NCI reported that cannabidiol in animal studies was found to have anxiolytic (anxiety reduction) properties though the exact mechanisms are unknown at this time as well as doesn’t provide a high to users that is often found in cannabis users and can bring on anxiety as well. Some evidence has shown that cannabidiol can counteract feelings of anxiety brought on by THC.

An article in Neurology Today from January 2017 stated that various animal studies on cannabidiol oil “shows promise in treating seizure disorders, but questions remain about proper dosages to apply, the potential for adverse effects, and the drug-drug interactions with other antiepileptic drugs (AEDS).”

A US Government Patent states that cannabinoids have antioxidant properties and that this trait can make cannabidiol and other cannabinoids a useful in the treatment of as ischemic, age-related, inflammatory, and autoimmune diseases. This Patent states that cannabidiol “prevent[s]or treat[s] diseases caused by oxidative stress,” and can penetrate tissues thus enabling them to enter the central nervous system and brain.

NIDA also noted that cannabidiol has neuroprotective properties in animal studies. This includes neurodegenerative diseases such as Alzheimer’s Parkinson’s, and Multiple Sclerosis. A research team in China also reported that cannabidiol “had been shown to reverse the reduction in neuronal viability and the increased excitoxicity, inflammation, and oxidative stress.”

Cannabidiol research is expanding and with each new study further benefits and uses are being found.


There are no products